research articles (9) Peri, S.; Navarro, J. D.; Amanchy, R.; Kristiansen, T. Z.; Jonnala- gadda, C. K.; Surendranath, V.; Niranjan, V.; Muthusamy, B.; Gandhi, T. K.; Gronborg, M.; Ibarrola, N.; Deshpande, N.; Shanker, K.; Shivashankar, H. N.; Rashmi, B. P.; Ramya, M. A.; Zhao, Z.; Chandrika, K. N.; Padma, N.; Harsha, H. C.; Yatish, A. J.; Kavitha, M. P.; Menezes, M.; Choudhury, D. R.; Suresh, S.; Ghosh, N.; Saravana, R.; Chandran, S.; Krishna, S.; Joy, M.; Anand, S. K.; Madavan, V.; Joseph, A.; Wong, G. W.; Schiemann, W. P.; Con- stantinescu, S. N.; Huang, L.; Khosravi-Far, R.; Steen, H.; Tewari, M.; Ghaffari, S.; Blobe, G. C.; Dang, C. V.; Garcia, J. G.; Pevsner, J.; Jensen, O. N.; Roepstorff, P.; Deshpande, K. S.; Chinnaiyan, A. M.; Hamosh, A.; Chakravarti, A.; Pandey, A. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 2003, 13, 2363–2371. (10) Amanchy, R.; Kalume, D. E.; Iwahori, A.; Zhong, J.; Pandey, A. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J. Proteome Res. 2005, 4, 1661–1671. (11) Ibarrola, N.; Molina, H.; Iwahori, A.; Pandey, A. A novel proteomic approach for speciﬁc identiﬁcation of tyrosine kinase substrates using [13C]tyrosine. J. Biol. Chem. 2004, 279, 15805–15813. (12) Kratchmarova, I.; Blagoev, B.; Haack-Sorensen, M.; Kassem, M.; Mann, M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308, 1472– 1477. (13) Pandey, A.; Podtelejnikov, A. V.; Blagoev, B.; Bustelo, X. R.; Mann, M.; Lodish, H. F. Analysis of receptor signaling pathways by mass spectrometry: identiﬁcation of vav-2 as a substrate of the epider- mal and platelet-derived growth factor receptors. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 179–184. (14) Rush, J.; Moritz, A.; Lee, K. A.; Guo, A.; Goss, V. L.; Spek, E. J.; Zhang, H.; Zha, X. M.; Polakiewicz, R. D.; Comb, M. J. Immunoafﬁnity proﬁling of tyrosine phosphorylation in cancer cells. Nat. Biotech- nol. 2005, 23, 94–101. (15) Amanchy, R.; Kalume, D. E.; Pandey, A. (2005) Stable isotope labeling with amino acids in cell culture (SILAC) for studying dynamics of protein abundance and posttranslational modiﬁca- tions. Sci. STKE 2005, 12. (16) Schulze, W. X.; Mann, M. A novel proteomic screen for peptide- protein interactions. J. Biol. Chem. 2004, 279, 10756–10764. (17) Molina, H.; Parmigiani, G.; Pandey, A. Assessing reproducibility of a protein dynamics study using in vivo labeling and liquid chromatography tandem mass spectrometry. Anal. Chem. 2005, 77, 2739–2744. (18) Diks, S. H.; Kok, K.; O’Toole, T.; Hommes, D. W.; van Dijken, P.; Joore, J.; Peppelenbosch, M. P. Kinome proﬁling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 2004, 279, 49206–49213. (19) Cleveland, W. S., andLoader, C. R. Smoothing by Local Regression: Principles and Methods; Technical Report; AT&T Bell Laboratories: Murray Hill, NY, 1995. (20) Cooper, J. A.; Gould, K. L.; Cartwright, C. A.; Hunter, T. Tyr527 is phosphorylated in pp60c-src: implications for regulation. Science 1986, 231, 1431–1434. (21) Bagrodia, S.; Chackalaparampil, I.; Kmiecik, T. E.; Shalloway, D. Altered tyrosine 527 phosphorylation and mitotic activation of p60c-src. Nature 1991, 349, 172–175. (22) Kaplan, K. B.; Bibbins, K. B.; Swedlow, J. R.; Arnaud, M.; Morgan, D. O.; Varmus, H. E. Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J. 1994, 13, 4745–4756. (23) Thomas, J. E.; Soriano, P.; Brugge, J. S. Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase. Science 1991, 254, 568–571. (24) Schuh, S. M.; Brugge, J. S. Investigation of factors that inﬂuence phosphorylation of pp60c-src on tyrosine 527. Mol. Cell. Biol. 1988, 8, 2465–2471. (25) Luttrell, L. M.; Hawes, B. E.; van Biesen, T.; Luttrell, D. K.; Lansing, T. J.; Lefkowitz, R. J. Role of c-Src tyrosine kinase in G protein- coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J. Biol. Chem. 1996, 271, 19443–19450. (26) Chang, J. H.; Wilson, L. K.; Moyers, J. S.; Zhang, K.; Parsons, S. J. Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors. Oncogene 1993, 8, 959–967. 3910 Journal of Proteome Research Vol. 7, No. 9, 2008 Amanchy et al. (27) Kim, J.; Lee, J. M.; Branton, P. E.; Pelletier, J. Modulation of EWS/ WT1 activity by the v-Src protein tyrosine kinase. FEBS Lett. 2000, 474, 121–128. (28) Huang, C.; Liu, J.; Haudenschild, C. C.; Zhan, X. The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J. Biol. Chem. 1998, 273, 25770–25776. (29) Abouzaglou, J.; Benistant, C.; Gimona, M.; Roustan, C.; Kassab, R.; Fattoum, A. Tyrosine phosphorylation of calponins. Inhibition of the interaction with F-Actin. Eur. J. Biochem. 2004, 271, 2615– 2623. (30) Ostareck-Lederer, A.; Ostareck, D. H.; Cans, C.; Neubauer, G.; Bomsztyk, K.; Superti-Furga, G.; Hentze, M. W. c-Src-mediated phosphorylation of hnRNP K drives translational activation of speciﬁcally silenced mRNAs. Mol. Cell. Biol. 2002, 22, 4535–4543. (31) Yang, J. P.; Reddy, T. R.; Truong, K. T.; Suhasini, M.; Wong-Staal, F. Functional interaction of Sam68 and heterogeneous nuclear ribonucleoprotein K. Oncogene 2002, 21, 7187–7194. (32) Rahmouni, S.; Vang, T.; Alonso, A.; Williams, S.; van Stipdonk, M.; Soncini, C.; Moutschen, M.; Schoenberger, S. P.; Mustelin, T. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein. Mol. Cell. Biol. 2005, 25, 2227–2241. (33) Parker, F.; Maurier, F.; Delumeau, I.; Duchesne, M.; Faucher, D.; Debussche, L.; Dugue, A.; Schweighoffer, F.; Tocque, B. A Ras- GTPase-activating protein SH3-domain-binding protein. Mol. Cell. Biol. 1996, 16, 2561–2569. (34) Cichowski, K.; McCormick, F.; Brugge, J. S. p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. J. Biol. Chem. 1992, 267, 5025–5028. (35) Kmiecik, T. E.; Shalloway, D. Activation and suppression of pp60c- src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 1987, 49, 65–73. (36) Ohan, N.; Sabourin, D.; Booth, R. A.; Liu, X. J. Xenopus laevis TRK- fused gene (TFG) is an SH3 domain binding protein highly expressed in the cement gland. Mol. Reprod. Dev. 2000, 56, 336– 344. (37) Broome, M. A.; Hunter, T. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling. J. Biol. Chem. 1996, 271, 16798–16806. (38) Blake, R. A.; Broome, M. A.; Liu, X.; Wu, J.; Gishizky, M.; Sun, L.; Courtneidge, S. A. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 2000, 20, 9018–9027. (39) Shah, K.; Vincent, F. Divergent roles of c-Src in controlling platelet- derived growth factor-dependent signaling in ﬁbroblasts. Mol. Biol. Cell 2005, 16, 5418–5432. (40) Delattre, O.; Zucman, J.; Plougastel, B.; Desmaze, C.; Melot, T.; Peter, M.; Kovar, H.; Joubert, I.; de Jong, P.; Rouleau, G.; et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992, 359, 162–165. (41) Prieur, A.; Tirode, F.; Cohen, P.; Delattre, O. EWS/FLI-1 silencing and gene proﬁling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 2004, 24, 7275–7283. (42) Nozawa, S.; Ohno, T.; Banno, Y.; Dohjima, T.; Wakahara, K.; Fan, D. G.; Shimizu, K. Inhibition of platelet-derived growth factor- induced cell growth signaling by a short interfering RNA for EWS- Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells. J. Biol. Chem. 2005, 280, 27544–27551. (43) Kasof, G. M.; Goyal, L.; White, E. Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins. Mol. Cell. Biol. 1999, 19, 4390–4404. (44) Martinez-Arribas, F.; Agudo, D.; Pollan, M.; Gomez-Esquer, F.; Diaz-Gil, G.; Lucas, R.; Schneider, J. Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J. Cell. Biochem. 2006, 97, 1275–1282. (45) Bernhard, O. K.; Cunningham, A. L.; Sheil, M. M. Analysis of proteins copurifying with the CD4/lck complex using one- dimensional polyacrylamide gel electrophoresis and mass spec- trometry: comparison with afﬁnity-tag based protein detection and evaluation of different solubilization methods. J. Am. Soc. Mass Spectrom. 2004, 15, 558–567. (46) Scott, M. P.; Zappacosta, F.; Kim, E. Y.; Annan, R. S.; Miller, W. T. Identiﬁcation of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP- interacting protein (WIP), and ELMO1. J. Biol. Chem. 2002, 277, 28238–28246. PR800198W